A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome

Anesthesia and Analgesia

Volumn 85, Issue 3, 1997, Pages 507-513

  Kunimoto, Fumio ^a   Arai, Kenichi ^a   Isa, Yukitaka ^a   Koyano, Tetsuya ^a   Kadoi, Yuji ^a   Saito, Shigeru ^a   Goto, Fumio ^a  

^a GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LUNG VASCULAR RESISTANCE; MALE; MITRAL VALVE REPLACEMENT; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ADULT; AGED; ALPROSTADIL; BLOOD PRESSURE; FEMALE; HEART VALVE PROSTHESIS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MITRAL VALVE; OXYGEN; POSTOPERATIVE COMPLICATIONS; PULMONARY ARTERY; PULMONARY CIRCULATION; RESPIRATORY DISTRESS SYNDROME, ADULT; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0030752607     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199709000-00006     Document Type: Article

References (18)

1. Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br Heart J 1975;37:74-8.
2. Kaul TK, Bain WH, Jones CJ, et al. Mitral valve replacement in the presence of severe pulmonary hypertension. Thorax 1976; 31:332-6.
3. Zapol W, Snider M. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 1977;296:476-80.
4. Sibbald WJ, Paterson NA, Holliday RL, et al. Pulmonary hypertension in sepsis. Chest 1978;75:583-91.
5. Wagenvoort CA, Wagenvoort N. Pathology of pulmonary hypertension. New York: John Wiley & Sons, 1977.
6. Zapol WM, Snider MT, Rie MA, et al. Pulmonary circulation during adult respiratory distress syndrome. In: Zapol WM, Falke KJ, eds. Acute respiratory failure. Vol 24. New York: Marcel Dekker, 1985:241-73.
7. Ferreira SH, Vane JR. Prostaglandins: their disapearance from and release into the circulation. Nature 1967;216:868-73.
8. D'Ambra MN, LaRaia PJ, Philbin DM, et al. Prostaglandin E1: a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg 1985;89:567-72.
9. Mikawa K, Maekawa N, Goto R, et al. Use of prostaglandin E1 to treat peri-anaesthetic pulmonary hypertension associated with mitral valve disease. J Int Med Res 1993;21:161-4.
10. Radermacher P, Santak B, Becker H, Falke KJ. Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 1989;70: 601-6.
11. Melot C, Lejeune P, Leeman M, et al. Prostaglandin E1 in the adult respiratory distress syndrome: benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis 1989;139:106-10.
12. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3.
13. Jaffe BM, Behrman HR, Parker CW. Radioimmunoassay measurement of prostaglandins E, A and F in human plasma. J Clin Invest 1973;52:398-405.
14. Bakhle YS, Vane JR. Pharmacokinetic function of the pulmonary circulation. Physiol Rev 1974;54:1007-45.
15. Junod AF. Metabolism, production and release of hormones and mediators in the lung. Am Rev Respir Dis 1975;112:93-108.
16. Morel DR, Dargent F, Bachmann M, et al. Pulmonary extraction of serotonin and propranolol in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:479-84.
17. Anggard E, Larsson CTI. The sequence of the early steps in the metabolism of prostaglandin E1. Eur J Pharmacol 1971;14:66-70.
18. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee of the American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.